Rachel M Greer

Rachel M Greer, B.Sc.

  • Position:
    Graduate Student - Ph.D.

    Hamon Center for Therapeutic Oncology Research

    Cell Regulation

    University of Texas Southwestern Medical Center (Dallas, TX)

  •  
  • Advisor:

    John D. Minna

  •  
  • Degrees:
     
    B.Sc., Biochemistry, Trinity University (San Antonio, TX)
  •  
  • Past Advisors:
     
    Bert Chandler (as Undergraduate Student)
  •  
  • Research:
    Determine how to rationally combine chemotherapies to maximize anti-tumor effect on NSCLC.

    Using pre-clinical models of lung cancer, both in vitro and in vivo, evaluate the effectiveness of combinations of chemotherapies in order to be able to learn how to rationally combine them for maximal anti-tumor effect.

  •  
  •  
  • Honors:

    2004-2005 Beckman Scholar

    2003-2005 Dean's List

Life Sciences
Communities:

Rachel Greer's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.


Rachel Greer's Posters and Presentations (9)

  • Antigene RNAs targeted to the TP53 promoter are potent inhibitors of tumor cell growth and survival (poster)

    David S. Shames, Rachel M. Greer, Jacob C. Schwartz, Sean Dineen, James P. Sullivan, Robin

    American Association for Cancer Research, National Conference 2008; 04/2008
  • Diazonamide A Analogue (JP-1036), a Novel Anti-mitotic, Has Potent Anti-tumor Activity in Subset of Non-small Cell Lung Cancers Distinct From Other Anti-neoplastics (poster)

    Rachel Greer, Luc Girard, Michael Peyton, Stephanie Weber, Gelin Wang, Yang Xie, Qi Wei, Noelle Williams, Patrick Harran,

    American Association for Cancer Research, National Conference 2008; 04/2008
  • microRNA regulation of chemoresistance in non-small cell lung cancer (NSCLC) (poster)

    Liqin Du, Rachel M. Greer, Jeoffrey J. Schageman, Adi F. Gazdar, Scott M. Hammond,

    American Association for Cancer Research, National Conference 2008; 04/2008
  • Peloruside A combinations with paclitaxel or vinorelbine improves the dose response effect in a panel of NSCLC (poster)

    Stephanie Weber, Michael Peyton, James P. Sullivan, Rachel Greer, Luc Girard, Yang Xie, Adi Gazdar,

    American Association for Cancer Research, National Conference 2008; 04/2008
  • Diazonamide A Analogue (JP-1036), a Novel Anti-mitotic, Has Potent Anti-tumor Activity in Subset of Non-small Cell Lung Cancers Distinct From Other Anti-neoplastics (poster)

    Rachel Greer, Luc Girard, Michael Peyton, Stephanie Weber, Gelin Wang, Yang Xie, Qi Wei, Noelle Williams, Patrick Harran, Xiaodong Wang, Steven McKnight, John Minna

    International Association for the Study of Lung Cancer, 8th Annual Targeted Therapies of the Treatment of Lung Cancer; 02/2008
  • Antigene RNAs Targeted to the TP53 Promoter Are Potent Inhibitors of Tumor Cell Growth and Survival (poster)

    David S. Shames, Rachel M. Greer, Jacob C. Schwartz, Sean Dineen, James P. Sullivan, Robin Frink, Mitsuo Sato, Boning Gao, Michael Peyton, Alice Smith, Adi F.

    University of Texas Southwestern Medical Center, Annual Post Doctoral Poster Session; 11/2007
  • Differential Effects of Peloruside A Compared to Paclitaxel and Vinorelbine on (poster)

    Michael Peyton, Stephanie Weber, Rachel Greer, Luc Girard, Adi F. Gazdar, Jef De Brabander, and John D. Minna

    American Association for Cancer Research, National Conference 2007; 04/2007
  • SMAC Mimetic Combined with Conventional Chemotherapy Agents Yields Synergy in the Treatment of Non-Small Cell Lung Cancer (poster)

    Rachel M. Greer, Michael Peyton, Sunny Zachariah, Luc Girard, Noelle Williams, Patrick Harran, Xiaodong Wang, John D. Minna

    American Association for Cancer Research, National Conference 2007; 04/2007
  • SMAC Mimetic combined with conventional chemotherapy agents yields synergy in the treatment of Non-Small Cell Lung Cancer (poster)

    Rachel M. Greer, Michael Peyton, Sunny Zachariah, Luc Girard, Noelle Williams, Patrick Harran, Xiaodong Wang, John D. Minna

    International Association for the Study of Lung Cancer, 7th Annual Targeted Therapies of the Treatment of Lung Cancer; 02/2007

Join Epernicus (membership is free)
Epernicus is open to current and former research scientists.
First name:
Last name:
Email:

(we don't share your email)

Already a member?
Sign in to view Rachel's full profile.